Opendata, web and dolomites

VEMoS SIGNED

Virtual eye model system for personalised refractive surgery treatment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 VEMoS project word cloud

Explore the words cloud of the VEMoS project. It provides you a very rough idea of what is the project "VEMoS" about.

clinics    innovation    vemos    combining    impairments    37m    children    profit    quantified    predicted    145    tech    worldwide    ophthalmology    drivers    create    topographer    chuc    reduce    reported    icpermed    skills    vulnerable    spent    50    patient    productivity    revolutionise    revolutionary    incidence    generating    vision    almost    simulations    successful    ms    manufacturing    clients    2022    standardise    simulation    2m    population    uncorrected    patented    independent    front    death    3m    revenue    equal    post    social    tomographer    customer    provides    software    241bn    progress    surgery    full    28    hours    companies    ophthalmic    employments    diagnostic    myopia    responsible    model    virtual    vissum    screens    health    aging    driving    clinical    educational    hardware    workers    economic    ec    global    satisfaction    quality    measurable    time    network    action    rates    deficits    life    neural    treatments    aberrometer    plan    commercialisation    39    innovative    58    accumulated    elderly    outcomes    impacts    2010    personalised    mature    auh    groups    2050    risk    medicine    refractive    cso    eye    2026    decision   

Project "VEMoS" data sheet

The following table provides information about the project.

Coordinator
VALCASADO SA 

Organization address
address: EBANISTAS 4
city: ALCORCON
postcode: 28923
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙935˙335 €
 EC max contribution 2˙997˙269 € (76%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2022-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VALCASADO SA ES (ALCORCON) coordinator 1˙426˙919.00
2    COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL IT (BADIA A SETTIMO) participant 761˙902.00
3    AARHUS UNIVERSITETSHOSPITAL DK (AARHUS) participant 406˙371.00
4    CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA E.P.E. PT (COIMBRA) participant 402˙076.00

Map

 Project objective

The incidence of myopia is predicted to rise from 28% of the global population in 2010 to almost 50% in 2050. Factors such as population aging and increase of hours spent in front of screens are driving the increase in global eye deficits. Vision impairments reduce the quality of life, affect economic and educational opportunities and increase the risk of death. This is particularly important for vulnerable groups such as elderly, children, workers and drivers. Overall, WHO reported that uncorrected vision was responsible for €241bn of productivity loss per year worldwide. Our innovative Virtual Eye Model System (VEMoS) is based on patented revolutionary ophthalmic diagnostic devices (CSO’s MS-39 tomographer/topographer and the unique open-field aberrometer), as well as on innovative simulation software developed by Vissum. Overall, our innovation provides personalised clinical-decision support based on each patient’s eye measurements and neural network simulations of post-surgery outcomes, improving surgery success and patient satisfaction rates. By combining CSO’s ophthalmic high-tech hardware design, manufacturing and commercialisation skills with Vissum’s refractive surgery and software development and independent clinical testing by CHUC and AUH, this project is expected to bring economic, social and health impacts, including progress towards achieving the EC action plan on personalised medicine “ICPerMed”. Our goal is to mature, scale-up and demonstrate the production of the VEMoS system, targeting ophthalmology clinics as clients, and with the aim to standardise refractive surgery decision making and revolutionise the refractive surgery field with personalised treatments. A successful VEMoS project will allow us to create measurable impacts on our companies, quantified as accumulated revenue of €145.3m in five years (2022-2026), equal to accumulated operating profit of €58.2m, creating 60 full time employments, and generating €37m in reduced customer costs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VEMOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VEMOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

De-RISC (2019)

De-RISC: Dependable Real-time Infrastructure for Safety-critical Computer

Read More  

PAV-DT (2019)

A disruptive technology that enables low cost real-time monitoring of road pavement condition by any ordinary vehicle circulating on the road, and automatically designs plans for predictive maintenance.

Read More  

PATH-TOX (2018)

Artificial Intelligence to transform Drug and Chemical safety testing

Read More